Literature DB >> 22179615

Identification and functional impact of homo-oligomers of the human proton-coupled folate transporter.

Zhanjun Hou1, Sita Kugel Desmoulin, Erika Etnyre, Mary Olive, Benjamin Hsiung, Christina Cherian, Patrick A Wloszczynski, Kamiar Moin, Larry H Matherly.   

Abstract

The proton-coupled folate transporter (PCFT; SLC46A1) is a proton-folate symporter that is abundantly expressed in solid tumors and normal tissues, such as duodenum. The acidic pH optimum for PCFT is relevant to intestinal absorption of folates and could afford a means of selectively targeting tumors with novel cytotoxic antifolates. PCFT is a member of the major facilitator superfamily of transporters. Because major facilitator superfamily members exist as homo-oligomers, we tested this for PCFT because such structures could be significant to PCFT mechanism and regulation. By transiently expressing PCFT in reduced folate carrier- and PCFT-null HeLa (R1-11) cells and chemical cross-linking with 1,1-methanediyl bismethanethiosulfonate and Western blotting, PCFT species with molecular masses approximating those of the PCFT dimer and higher order oligomers were detected. Blue native polyacrylamide gel electrophoresis identified PCFT dimer, trimer, and tetramer forms. PCFT monomers with hemagglutinin and His(10) epitope tags were co-expressed in R1-11 cells, solubilized, and bound to nickel affinity columns, establishing their physical associations. Co-expressing YPet and ECFP*-tagged PCFT monomers enabled transport and fluorescence resonance energy transfer in plasma membranes of R1-11 cells. Combined wild-type (WT) and inactive mutant P425R PCFTs were targeted to the cell surface by surface biotinylation/Western blots and confocal microscopy and functionally exhibited a "dominant-positive" phenotype, implying positive cooperativity between PCFT monomers and functional rescue of mutant by WT PCFT. Our results demonstrate the existence of PCFT homo-oligomers and imply their functional and regulatory impact. Better understanding of these higher order PCFT structures may lead to therapeutic applications related to folate uptake in hereditary folate malabsorption, and delivery of PCFT-targeted chemotherapy drugs for cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22179615      PMCID: PMC3281668          DOI: 10.1074/jbc.M111.306860

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  62 in total

Review 1.  Imaging biochemistry inside cells.

Authors:  F S Wouters; P J Verveer; P I Bastiaens
Journal:  Trends Cell Biol       Date:  2001-05       Impact factor: 20.808

2.  Structure and mechanism of the lactose permease of Escherichia coli.

Authors:  Jeff Abramson; Irina Smirnova; Vladimir Kasho; Gillian Verner; H Ronald Kaback; So Iwata
Journal:  Science       Date:  2003-08-01       Impact factor: 47.728

3.  Determination of the subunit stoichiometry of a voltage-activated potassium channel.

Authors:  R MacKinnon
Journal:  Nature       Date:  1991-03-21       Impact factor: 49.962

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Properties of the Arg376 residue of the proton-coupled folate transporter (PCFT-SLC46A1) and a glutamine mutant causing hereditary folate malabsorption.

Authors:  Kris Mahadeo; Ndeye Diop-Bove; Daniel Shin; Ersin Selcuk Unal; Juliana Teo; Rongbao Zhao; Min-Hwang Chang; Andreas Fulterer; Michael F Romero; I David Goldman
Journal:  Am J Physiol Cell Physiol       Date:  2010-08-04       Impact factor: 4.249

6.  Cysteine-directed cross-linking localizes regions of the human erythrocyte anion-exchange protein (AE1) relative to the dimeric interface.

Authors:  A M Taylor; Q Zhu; J R Casey
Journal:  Biochem J       Date:  2001-11-01       Impact factor: 3.857

7.  Identification of novel mutations in the proton-coupled folate transporter (PCFT-SLC46A1) associated with hereditary folate malabsorption.

Authors:  Daniel Sanghoon Shin; Kris Mahadeo; Sang Hee Min; Ndeye Diop-Bove; Peter Clayton; Rongbao Zhao; I David Goldman
Journal:  Mol Genet Metab       Date:  2011-01-25       Impact factor: 4.797

8.  A prominent low-pH methotrexate transport activity in human solid tumors: contribution to the preservation of methotrexate pharmacologic activity in HeLa cells lacking the reduced folate carrier.

Authors:  Rongbao Zhao; Feng Gao; Marie Hanscom; I David Goldman
Journal:  Clin Cancer Res       Date:  2004-01-15       Impact factor: 12.531

9.  Oligomeric structure of the human reduced folate carrier: identification of homo-oligomers and dominant-negative effects on carrier expression and function.

Authors:  Zhanjun Hou; Larry H Matherly
Journal:  J Biol Chem       Date:  2008-11-19       Impact factor: 5.157

10.  Reversible severe combined immunodeficiency phenotype secondary to a mutation of the proton-coupled folate transporter.

Authors:  Arturo Borzutzky; Brian Crompton; Anke K Bergmann; Silvia Giliani; Sachin Baxi; Madelena Martin; Ellis J Neufeld; Luigi D Notarangelo
Journal:  Clin Immunol       Date:  2009-09-09       Impact factor: 3.969

View more
  26 in total

1.  Structural determinants of human proton-coupled folate transporter oligomerization: role of GXXXG motifs and identification of oligomeric interfaces at transmembrane domains 3 and 6.

Authors:  Mike R Wilson; Sita Kugel; Jenny Huang; Lucas J Wilson; Patrick A Wloszczynski; Jun Ye; Larry H Matherly; Zhanjun Hou
Journal:  Biochem J       Date:  2015-04-16       Impact factor: 3.857

2.  Therapeutic targeting malignant mesothelioma with a novel 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl antifolate via its selective uptake by the proton-coupled folate transporter.

Authors:  Christina Cherian; Sita Kugel Desmoulin; Lei Wang; Lisa Polin; Kathryn White; Juiwanna Kushner; Mark Stout; Zhanjun Hou; Aleem Gangjee; Larry H Matherly
Journal:  Cancer Chemother Pharmacol       Date:  2013-02-15       Impact factor: 3.333

Review 3.  The proton-coupled folate transporter (PCFT-SLC46A1) and the syndrome of systemic and cerebral folate deficiency of infancy: Hereditary folate malabsorption.

Authors:  Rongbao Zhao; Srinivas Aluri; I David Goldman
Journal:  Mol Aspects Med       Date:  2016-09-21

Review 4.  The promise and challenges of exploiting the proton-coupled folate transporter for selective therapeutic targeting of cancer.

Authors:  Larry H Matherly; Zhanjun Hou; Aleem Gangjee
Journal:  Cancer Chemother Pharmacol       Date:  2017-11-10       Impact factor: 3.333

5.  Dual Targeting of Epithelial Ovarian Cancer Via Folate Receptor α and the Proton-Coupled Folate Transporter with 6-Substituted Pyrrolo[2,3-d]pyrimidine Antifolates.

Authors:  Zhanjun Hou; Leda Gattoc; Carrie O'Connor; Si Yang; Adrianne Wallace-Povirk; Christina George; Steve Orr; Lisa Polin; Kathryn White; Juiwanna Kushner; Robert T Morris; Aleem Gangjee; Larry H Matherly
Journal:  Mol Cancer Ther       Date:  2017-01-30       Impact factor: 6.261

Review 6.  The proton-coupled folate transporter: physiological and pharmacological roles.

Authors:  Rongbao Zhao; I David Goldman
Journal:  Curr Opin Pharmacol       Date:  2013-12       Impact factor: 5.547

Review 7.  The major facilitative folate transporters solute carrier 19A1 and solute carrier 46A1: biology and role in antifolate chemotherapy of cancer.

Authors:  Larry H Matherly; Mike R Wilson; Zhanjun Hou
Journal:  Drug Metab Dispos       Date:  2014-01-06       Impact factor: 3.922

8.  Functional loss of the reduced folate carrier enhances the antitumor activities of novel antifolates with selective uptake by the proton-coupled folate transporter.

Authors:  Sita Kugel Desmoulin; Lei Wang; Lisa Polin; Kathryn White; Juiwanna Kushner; Mark Stout; Zhanjun Hou; Christina Cherian; Aleem Gangjee; Larry H Matherly
Journal:  Mol Pharmacol       Date:  2012-06-26       Impact factor: 4.436

Review 9.  Biology of the major facilitative folate transporters SLC19A1 and SLC46A1.

Authors:  Zhanjun Hou; Larry H Matherly
Journal:  Curr Top Membr       Date:  2014       Impact factor: 3.049

10.  Substituted cysteine accessibility reveals a novel transmembrane 2-3 reentrant loop and functional role for transmembrane domain 2 in the human proton-coupled folate transporter.

Authors:  Mike R Wilson; Zhanjun Hou; Larry H Matherly
Journal:  J Biol Chem       Date:  2014-07-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.